Disclosures for "Caroticocavernous Fistulae: A Real World Comparison of Clinicoradiographic Features and Treatment Approaches"
-
Dr. Vranic has nothing to disclose.
-
Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.
-
Dr. Awad has nothing to disclose.
-
James D. Rabinov has stock in Pfizer.